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Abstract
Neuronal apoptosis is involved in neurodegenerative diseases such as Alzheimer’s disease and
Parkinson.s disease. An efficient means of preventing it remains to be found. Some n-3 polyunsat-
urated fatty acids (PUFAs) such as docosahexaenoic acid (DHA, 22 : 6n-3) and eicosapentaenoic
acid (EPA, 20 : 5n-3) have been reported to be protective against the neuronal apoptosis and neu-
ronal degeneration seen after spinal cord injury (SCI) [1]. However, it is unclear which kinds of
PUFAs have the most potent ability to inhibit neuronal apoptosis and whether the simultaneous
treatment of PUFAs inhibits the apoptosis. In the present study, we compared the abilities of var-
ious n-3- and n-6- PUFAs to inhibit the apoptosis induced after the administration of different
apoptotic inducers, etoposide, okadaic acid, and AraC, in mouse neuroblastoma cells (Neuro2a).
Preincubation with DHA (22 : 6n-3), eicosapentaenoic acid (EPA, 20 : 5n-3), alpha-linolenic
acid (alpha-LNA, 18 : 3n-3), linoleic acid (LA, 18 : 2n-6), arachidonic acid (AA, 20 : 4n-3), and
gamma-linolenic acid (gamma-LNA, 18 : 3n-6) significantly inhibited caspase-3 activity and LDH
leakage but simultaneous treatment with the PUFAs had no effect on the apoptosis of Neuro2a
cells. There were no significant differences of the anti-apoptotic eff ect among the PUFAs. These
results suggest that PUFAs may not be effective for inhibiting neuronal cell death after acute and
chronic neurodegenerative disorders. However, dietary supplementation with PUFAs may be ben-
eficial as a potential means to delay the onset of the diseases and/or their rate of progression.
KEYWORDS: polyunsaturated fatty acid (PUFA), neurodegenerative disease, caspase, neuronal
apoptosis, DHA
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ervous tissue has the second highest concen-
tration of fatty acids after adipose tissue.  The 
cell membrane consists of a double phospholipid layer 
incorporating both n-3 and n-6 long chain PUFAs (e.g., 
EPA,  DHA,  and arachidonic acid (AA)).  Both n-3 
and n-6 long chain PUFAs play important roles in 
neuronal growth,  the development of synaptic pro-
cessing during neural cell interactions,  and the 
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expression of genes regulating cell diﬀ erentiation and 
growth [2].  Long chain PUFA levels are particu-
larly high in the retina and cerebral cortex.  DHA 
can account for up to 50ｵ of phospholipid fatty 
acids in these tissues,  suggesting that it is heavily 
involved in neuronal and visual functions [2].
　　DHA has garnered much attention for its poten-
tial in treating certain diseases,  cancers [3] and 
neurodegenerative disorders such as Parkinson’s and 
Alzheimer’s disease [4].  The anti-cancer action of 
DHA is mainly due to its apoptotic eﬀ ects [5].  It 
also shows anti-apoptotic eﬀ ects in neuronal cell lines 
and primary neurons [6ﾝ9].  Previous studies have 
shown the molecular mechanism of the anti-apoptotic 
eﬀ ect of DHA.  DHA exerts its protective eﬀ ects due 
to its role as a neurotrophic factor,  its activation of 
the ERK/MAPK pathway,  or activation of some sur-
vival signaling cascades [6,  8,  10].
　　Previous studies showed that preincubation with 
some other PUFAs such as AA and linolenic acid 
(LNA,  18 : 3n-6) also had anti-apoptotic eﬀ ects in 
neurons [1,  11,  12].  However,  it is not known 
which kinds of PUFAs are most useful for the inhibi-
tion of neuronal apoptosis,  since comparative studies 
of the anti-apoptotic eﬀ ects of various PUFAs have 
not been done.  Moreover,  it is unclear whether 
PUFAs are eﬀ ective against acute and chronic neu-
rodegenerative disorders since the inhibitory eﬀ ect 
of simultaneous treatment with PUFAs on neuronal 
apoptosis has not been studied.
　　Neuro2a cells are a murine neuroblastoma cell 
line that has proven to be a useful experimental 
model for studying neuronal apoptosis since its apop-
tosis can be controlled by various conditions,  such as 
etoposide,  okadaic acid,  AraC or serum starvation. 
In the present study,  we compared the anti-apoptotic 
eﬀ ects of long chain PUFAs,  including n-3 and n-6 
PUFAs,  in Neuro2a cells and examined the inhibi-
tory eﬀ ect of simultaneous treatment with PUFAs on 
the apoptosis of the cells.
Materials and Methods
　　Cell culture.　 Mouse neuroblastoma Neuro2a 
cells were cultured in DMEM (Invitrogen,  San 
Diego,  CA,  USA) supplemented with 10ｵ fetal calf 
serum (FCS) and penicillin/streptomycin at 37 °C in 
an atmosphere of 95ｵ air and 5ｵ CO2.  The cells 
were exposed to DHA or other fatty acids (Funakoshi, 
Tokyo,  Japan) (FCS was reduced to 2ｵ),  etoposide 
(Sigma-Aldrich,  St.  Louis,  MO,  USA),  okadaic 
acid (Sigma-Aldrich),  or AraC (Nipponshinyaku, 
Tokyo,  Japan) 24 h after plating.  For the LDH 
activity assay,  the cells were seeded into 24-well 
plates at a density of 6 × 104 cells/well.  For the cas-
pase-3 activity assay,  the cells were seeded into T25 
ﬂ asks at a density of 1.0 × 106 cells / 10 ml.  For the 
DNA fragmentation assays,  the cells were seeded 
into T25 ﬂ asks at a density of 1.5 × 106 cells / 10 ml.
　　Trypan blue staining.　 The viability of the 
Neuro2a cells was determined by staining with try-
pan blue.  After the cells were stripped from the 
ﬂ ask,  they were stained with trypan blue and then 
counted with a hemocytometer.
　　Measurement of released LDH (lactate dehy-
drogenase) activity.　 The release of LDH from 
Neuro2a cells was measured as described previously 
[10].  Brieﬂ y,  after treatment with various apoptotic 
inducers in the presence or absence of DHA for 48 h, 
the cells were centrifuged at 250 g for 10 min at 
room temperature.  The supernatant (100 ｻl) was col-
lected and then incubated with 3 ml of reaction buﬀ er 
(16 mM KH2PO4,  84 mM K2HPO4,  2.4 mM NADH, 
and 23 mM sodium pyruvate,  pH 7.5).  The optical 
density,  reﬂ ecting the reduction of NADH,  which 
represents the amount of LDH released from 
Neuro2a cells,  was measured at 340 nm with a 
Shimadzu-UV3000 (Shimadzu,  Kyoto,  Japan).  The 
amount of LDH released was expressed as a percent-
age of the total pool of enzyme measured in negative 
control samples in which the cells were lysed with 1
ｵ Triton X-100.
　　Measurement of caspase-3 activity.　 After 
treatment with various apoptotic inducers in the 
presence or absence of DHA,  the cells were stripped 
from T25 ﬂ asks and washed with PBS (－) 2 times. 
The cells were then sonicated in extraction buﬀ er 
(25 mM HEPES (pH 7.5),  5 mM EGTA,  1 mM 
MgCl2,  5 mM DTT,  10 ｻg/ml pepstatinA,  10 ｻg/ml 
leupeptin,  1 mM PMSF and 0.1ｵ CHAPS) for 30 
sec on ice.  After centrifugation at 16,000 rpm for 
20 min at 4 °C,  the supernatant was collected and 
preserved at －80 °C until use.  Caspase-3 activity 
was determined by incubation of the supernatant 
(80 ｻg of protein) with 10 ｻM ﬂ uorogenic substrate 
Acetyl-DEVD-4-methyl-coumaryl-7-amide in caspase 
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assay buﬀ er (25 mM HEPES (pH 7.5),  5 mM DTT, 
10ｵ sucrose,  and 0.1ｵ CHAPS).  The release of 
7-amino-4-methylcoumarin was detected by ﬂ uorome-
try,  with excitation at 380 nm and emission at 
460 nm.
　　Assay of DNA fragmentation.　 After 48 h of 
treatment with various inducers of apoptosis with or 
without DHA,  the Neuro2a cells were harvested and 
lysed by incubation at 4 °C for 10 min in lysis buﬀ er 
(10 mM Tris-HCl,  10 mM EDTA,  and 0.5ｵ Triton 
X-100,  pH 7.5).  The cell lysates were centrifuged at 
15,000 rpm for 20 min.  The supernatant was incu-
bated with RNase A (400 ｻg/ml) at 37 °C for 1 h and 
then for an additional 30 min with proteinase K 
(400 ｻg/ml).  Fragmented DNA was precipitated with 
isopropyl alcohol and was electrophoresed in 1.6ｵ 
agarose gels.  The DNA ladders were visualized and 
photographed under UV light.
　　Statistical analysis.　 Data were expressed as 
the mean ± s.e.m.  Data were analyzed using Student’s 
t-test to compare 2 conditions and one-way ANOVA 
followed by planned comparisons of multiple condi-
tions,  and p ＜ 0.05 was considered to be signiﬁ cant.
Results
　　To optimize the eﬀ ects of DHA,  we examined the 
dose-dependent cell toxicity of DHA in Neuro2a cells 
(Fig.  1).  Cell toxicity was assessed by the inhibition 
of cell growth and released LDH activity.  Trypan 
blue staining revealed that none of the concentrations 
(10ﾝ50 ｻM) of DHA tested inhibited the cell growth 
at 24 h or 48 h of treatment (Fig.  1A).  However, 
incubation with high concentrations of DHA (20 and 
50 ｻM) for 72 h signiﬁ cantly inhibited the cell 
growth.  High-dose DHA (20 and 50 ｻM) induced the 
LDH activity in the cells,  whereas low-dose (5 and 
10 ｻM) DHA had no eﬀ ect on the induction of LDH 
activity (Fig.  1B).  These results suggest that long-
term treatment with high concentrations of DHA may 
cause cell toxicity such as the inhibition of cell 
growth and neuronal cell death,  and that 10 ｻM of 
DHA is an optimal concentration for avoiding cell 
toxicity.
　　We next examined the dose-dependent ability of 
DHA to inhibit the induction of apoptosis after the 
administration of etoposide (10 ｻM),  okadaic acid 
(40 nM),  AraC (100 ｻM) or serum starvation in 
Neuro2a cells.  The cells were preincubated with 
various concentrations (5,  10,  20 or 50 ｻM) of DHA 
for 24 h,  and were then induced to undergo apoptosis 
by adding various chemicals or subjecting them to 
serum starvation.  Preincubation with DHA attenu-
ated the inhibition of cell growth induced after the 
administration of the chemicals (Fig.  2A).  Each con-
centration of DHA tested (5ﾝ50 ｻM) signiﬁ cantly 
inhibited the ability of all of the chemicals to induce 
LDH activity (Fig.  2B).  A low concentration (5 ｻM) 
of DHA had no eﬀ ect on the inhibition of etoposide-
induced caspase-3 activity,  whereas 10 and 20 ｻM 
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Fig. 1　　Eﬀ ect of various concentrations of DHA on cell growth (A) and cytotoxicity (B) in Neuro2a cells.  A,  Counting of living cells. 
Neuro2a cells were treated with DHA (0ﾝ50 µM) for 24 h,  48 h,  or 72 h,  and the number of living cells was counted after trypan blue 
staining as described in “Materials and Methods” ; B,  The cells were treated with DHA (0ﾝ50 µM) for 72 h and the released LDH activity 
was then measured.  Data are shown as mean values (± s.e.m.) from 5 separate experiments.  ＊p ＜ 0.01.
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DHA inhibited the casapse-3 activity (Fig.  2 C). 
Each of these concentrations of DHA inhibited the 
induction of caspase-3 activity after the administra-
tion of other chemicals or serum starvation (Fig. 
2 C).  These results suggest that DHA (5ﾝ50 ｻM) 
inhibits neuronal apoptosis.
　　We next investigated whether simultaneous treat-
ment with DHA inhibited chemically induced apopto-
sis in Neuro2a cells.  The cells were simultaneously 
exposed to 10 ｻM DHA and each of various chemi-
cals (etoposide,  okadaic acid,  or AraC or serum 
starvation conditions),  and DNA fragmentation of the 
cells were examined 24 h after the treatment.  All of 
these chemicals and serum starvation induced DNA 
fragmentation (Fig.  3).  Simultaneous treatment with 
DHA did not aﬀ ect the induction of DNA fragmenta-
tion by any of these chemicals,  suggesting that the 
simultaneous treatment did not inhibit neuronal apop-
tosis.  In contrast,  preincubation with DHA inhibited 
the DNA fragmentation (Fig.  3).
　　Finally,  we examined whether other PUFAs had 
inhibitory eﬀ ects on neuronal apoptosis in Neuro2a 
cells.  For this,  the anti-apoptotic eﬀ ects of DHA, 
EPA AA and LA were examined.  As controls,  the 
inhibitory eﬀ ects of stearic acid (SA,  C18 : 0),  a sat-
urated fatty acid,  and oleic acid (OA,  C18 : 1,  n-9), 
a monosaturated fatty acid,  on neuronal apoptosis 
were examined.  SA showed no ability to inhibit the 
induction of apoptosis with any of the chemicals, 
(Figs.  4A and B).  OA inhibited the release of LDH 
activity induced after the administration of each 
chemical (Fig.  4A).  This fatty acid also inhibited 
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Fig. 2　　Inhibitory eﬀ ect of DHA on etoposide (etopo.  10 µM),  okadaic acid (Oka.,  40 nM),  or AraC (100 µM)-induced apoptosis in 
Neuro2a cells.  The cells were preincubated with DHA (10 µM) for 24 h and were then treated with each chemical for 12 h.  A,  Eﬀ ect of 
DHA on inhibition of cell growth induced by each chemical.  Bar ＝ 100 µm ; B,  Eﬀ ect of DHA on release of LDH activity.  The LDH 
activity was measured 48 h after incubation with each inducer of apoptosis ; C,  Eﬀ ect of DHA on caspase-3 activity.  SS,  serum 
starvation.  n ＝ 5 each.  ＊p ＜ 0.05,  ＊＊p ＜ 0.01.
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caspase-3 activity,  but the inhibitory eﬀ ect was 
weaker than that of the PUFAs (Fig.  4B).  All of the 
PUFAs tested (DHA,  EPA,  AA and LA) signiﬁ -
cantly inhibited both LDH activity and caspase-3 
activity,  and the inhibitory eﬀ ect was not obviously 
diﬀ erent among the PUFAs (Fig.  4).
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Fig. 4　　Comparison of inhibitory eﬀ ect of each PUFA on apoptosis in Neuro2a cells.  The cells were treated with each PUFA at 10 µM, 
and were then induced to undergo apoptosis with various chemicals.  SA,  stearic acid (C18 : 0) ; OA,  oleic acid (C18 : 1n-9) ; EPA, 
eicosapentaenoic acid (C20 : 5n-3) ; ｸ-LNA,  ｸ-linolenic acid (C18 : 3n-3) ; LA,  linoleic acid (C18 : 2n-6) ; AA,  arachidonic acid 
(C20 : 4n-6) ; ｺ-LNA,  ｺ-linolenic acid (C18 : 3n-6).  A,  Eﬀ ect of PUFAs on release of LDH activity ; B,  Eﬀ ect of PUFAs on caspase-3 
activity.  n ＝ 5 each,  ＊p ＜ 0.05 v.s.  Cont.,  ＊＊p ＜ 0.01 v.s.  Cont.,  ＊＊＊p ＜ 0.01 v.s.  OA.
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Fig. 3　　Comparison of the eﬀ ects of simultaneous treatment and pretreatment with DHA (10 µM) on DNA fragmentation of Neuro2a 
cells induced by various chemicals.  The cells were treated with 10 µM DHA for 24 h (preincubation) or were simultaneously treated with 
DHA plus each inducer of apoptosis,  etoposide (10 µM),  okadaic acid (40 nM),  AraC (100 µM) or serum starvation (simultaneous 
treatment).  After 24 h,  the cells were collected and DNA fragmentation in the cells was analyzed as described in “Materials and 
Methods”.
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Discussion
　　In the present study,  DHA (5ﾝ50 ｻM) had a pro-
tective eﬀ ect against apoptosis in Neuro2a cells,  but 
high concentrations of DHA (20 and 50 ｻM) caused 
cytotoxicity after 72 h of treatment (Fig.  1).  The 
cytotoxicity of DHA toward the cells may be consis-
tent with its anti-cancer eﬀ ect that has been reported 
previously [5].  A previous study showed that 5 or 
10 ｻM DHA did not have an anti-cancer eﬀ ect, 
whereas 20 and 30 ｻM DHA induced the apoptosis of 
cancer cells and inhibited cell growth [5].  These 
results suggest that DHA has contradictory eﬀ ects 
on cell growth and apoptosis,  and that the eﬀ ects are 
dose-dependent.  DHA at the concentration of 5 or 
10 ｻM may be most eﬀ ective for the inhibition of 
neuronal apoptosis without cytotoxicity.
　　The molecular mechanism of the neuroprotective 
eﬀ ect of DHA has not been elucidated.  In the pres-
ent study,  neuronal apoptosis was induced after the 
administration of diﬀ erent apoptotic inducers.  All 
these apoptotic inducers induce neuronal apoptosis 
by diﬀ erent mechanisms.  Etoposide is an inhibitor of 
the enzyme topoisomerase II,  blocking DNA re-liga-
tion and leading to direct DNA damage [13].  AraC 
acid (Cytarabine) is an inhibitor of DNA polymerase-
ｸ and -ｹ,  and acts by inhibiting DNA chain elonga-
tion [14].  Okadaic acid is an inhibitor of protein 
phosphatase 1,  2A and induces increases of cas-
pase-3 activity and DNA fragmentation through 
blocking dephosphorylation of some signal proteins 
[15].  However,  all of these chemicals induced cas-
pase activity and DHA inhibited the induction of cas-
pase activity and apoptosis by these chemicals in 
Neuro2a cells.  These results suggest that DHA may 
regulate the pathway of caspase activation.  In the 
present study,  other PUFAs in addition to DHA had 
protective eﬀ ects against neuronal apoptosis,  and the 
eﬀ ect was not signiﬁ cantly diﬀ erent among the 
PUFAs examined.  These results suggest that all n-3 
and n-6 PUFAs may have anti-apoptotic eﬀ ects 
through the regulation of the same signal pathway.
　　Neuronal apoptosis has been viewed to be involved 
in many neurodegenerative diseases,  such as 
Alzheimer’s disease and Parkinson’s disease. 
Preincubation with PUFAs inhibited neuronal apop-
tosis,  whereas simultaneous treatment failed to 
induce such inhibition.  These results suggest that 
PUFAs may not be eﬀ ective for inhibiting neuronal 
cell death after acute and chronic neurodegenerative 
disorders.  However,  dietary supplementation with 
PUFAs may be beneﬁ cial as a potential means of 
delaying the onset of the diseases and/or their rate 
of progression.
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